S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Germany
TG
Abbvie Inc (4AB)
Abbvie Inc (4AB) Financials

Abbvie Inc (4AB)

173.48

0.64

( 0.37% )

Updated: 01:00:49

Realtime Data

Abbvie Inc Financial Summary

The current 4AB market cap is 306.56B. The company's latest EPS is USD 2.7519 and P/E is 65.82.

Income Statement

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	34.16B	45.8B	56.2B	58.05B	54.5B
Operating Income	12.98B	11.36B	17.92B	18.12B	12.76B
Net Income	7.88B	4.62B	11.54B	11.84B	4.86B

Balance Sheet

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	89.12B	150.57B	146.53B	138.81B	134.71B
Total Liabilities	97.29B	137.47B	131.09B	121.52B	124.31B
Total Equity	-8.17B	13.1B	15.44B	17.29B	10.4B

Cash Flow

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Operating	13.32B	17.59B	22.78B	24.94B	22.84B
Investing	596M	-37.56B	-2.34B	-623M	-2.01B
Financing	18.71B	-11.5B	-19.04B	-24.8B	-17.22B

Stats and Ratios

Market Cap	306.56B
Price to Earnings Ratio	65.82
Price to Sales Ratio	5.87
Price to Cash Ratio	24.98
Price to Book Ratio	30.79
Dividend Yield	3.96%

Share Statistics

Shares Outstanding	1.77B
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-
Spread (Intraday)	0.56 (0.32%)

Company Info

Company Name	Abbvie Inc
Address	1521 concord pike suite 201 wilmington, delaware 19803
Website	https://www.abbvie.com
Industry	pharmaceutical preparations (2834)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions